Dsm 5 diagnosis
Pro Research Analysisby 
Searched over 200M research papers
DSM-5 Diagnosis: Advances, Challenges, and Implications
Introduction to DSM-5 Diagnosis
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has introduced significant changes in the diagnosis of various mental health conditions. This article explores the clinical validity, reliability, and implications of DSM-5 diagnostic criteria across several disorders, including attenuated psychosis syndrome, nonsuicidal self-injury disorder, autism spectrum disorder, major depressive disorder, and bipolar disorder.
Clinical Validity of DSM-5 Attenuated Psychosis Syndrome
The DSM-5 introduced the diagnosis of attenuated psychosis syndrome (APS) to identify individuals at high risk for developing psychosis. Research has shown that DSM-5-APS criteria have substantial concurrent and prognostic validation. The criteria are associated with frequent depressive comorbid disorders, distress, suicidality, and functional impairment. The meta-analytical risk of psychosis onset in individuals diagnosed with DSM-5-APS was found to be 11% at 6 months, 15% at 12 months, 20% at 24 months, and 23% at 36 months . However, research into predisposing factors, neurobiological correlates, and effective treatments remains limited.
Reliability of DSM-5 Diagnoses
The DSM-5 field trials aimed to assess the test-retest reliability of selected categorical diagnoses. The results indicated that most diagnoses had good to very good reliability, with intraclass kappa values ranging from 0.40 to 0.79 for the majority of tested diagnoses . This suggests that DSM-5 criteria are generally reliable when used in clinical settings with usual interview methods.
Nonsuicidal Self-Injury Disorder (NSSID)
The DSM-5 criteria for nonsuicidal self-injury disorder (NSSID) have been operationalized in empirical studies involving children, adolescents, and young adults. These studies have identified a sample of individuals with more general psychopathology and impairment compared to clinical controls and those with non-criteria meeting NSSI. Interpersonal difficulties and negative states preceding NSSI were highly endorsed, while the distress or impairment criterion had lower endorsement. Preliminary support exists for a distinct and independent NSSID diagnosis, but further empirical data are needed for reliable assessment and validation .
Impact of DSM-5 on Autism Spectrum Disorder Diagnosis
Changes in DSM-5 criteria for autism spectrum disorder (ASD) have led to a decrease in ASD diagnoses. Studies reported decreases ranging from 7.3% to 68.4%, with significant reductions in diagnoses of autistic disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS) 45. The DSM-5 criteria have higher specificity but lower sensitivity compared to DSM-IV-TR, potentially excluding a substantial portion of cognitively able individuals and those with ASDs other than autistic disorder 610. This has significant implications for service eligibility and research compatibility.
Major Depressive Disorder (MDD) and Its Specifiers
National data on DSM-5-defined major depressive disorder (MDD) indicate high prevalence, comorbidity, and disability. The 12-month and lifetime prevalences of MDD were 10.4% and 20.6%, respectively. The anxious/distressed specifier characterized 74.6% of MDD cases, while the mixed-features specifier characterized 15.5%. Both specifiers were associated with early onset, poor course and functioning, and suicidality . Despite most cases receiving some treatment, a substantial minority did not, highlighting the need for improved mental health services.
Bipolar Disorder: Prevalence and Validity
The DSM-5 and upcoming ICD-11 criteria for bipolar disorder suggest a substantial decrease in the point prevalence of the diagnosis compared to DSM-IV, ranging from 30-50%. However, the lifetime prevalence decrease is smaller, at around 6%. The changes may result in diagnostic delays and delayed early intervention, emphasizing the need for further research to validate the DSM-5 criteria for bipolar disorder .
Conclusion
The DSM-5 has introduced significant changes in the diagnosis of various mental health conditions, with implications for clinical practice, research, and public health. While the new criteria have improved specificity and reliability for some disorders, they have also led to decreased sensitivity and potential exclusion of certain populations. Ongoing research and empirical data are crucial to further validate and refine DSM-5 diagnostic criteria, ensuring accurate diagnosis and effective treatment for individuals with mental health disorders.
Sources and full results
Most relevant research papers on this topic
Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.
DSM-5 attenuated psychosis syndrome criteria have received substantial validation in recent years, but factors, neurobiological correlates, and effective treatments remain undetermined.
DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.
Most DSM-5 diagnoses showed good to very good reliability in assessing symptom expression and dimensionality in representative clinical populations.
The DSM-5 diagnosis of nonsuicidal self-injury disorder: a review of the empirical literature
The DSM-5 criteria show preliminary support for a distinct and independent diagnosis of nonsuicidal self-injury disorder in children, adolescents, and young adults.
How has DSM-5 Affected Autism Diagnosis? A 5-Year Follow-Up Systematic Literature Review and Meta-analysis
DSM-5 has led to smaller decreases in autism spectrum disorder diagnoses compared to earlier reviews, but the impact of social communication disorder remains unclear.
Validation of Proposed DSM-5 Criteria for Autism Spectrum Disorder
The proposed DSM-5 criteria for autism spectrum disorder (ASD) are valid and have increased specificity compared to DSM-IV-TR criteria, but a relaxed algorithm may improve identification and reduce missed cases.
DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions
The DSM-5 may impact clinical practice in various psychiatric areas, including autism, trauma-related disorders, obsessive-compulsive disorders, mood disorders, and schizophrenia spectrum disorders.
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
DSM-5 major depressive disorder prevalence in the US is 10.4%, with higher rates in younger adults, those with low incomes, and those with psychiatric disorders.
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network.
The use of DSM-5 and ICD-11 may result in diagnostic delay and delayed early intervention in bipolar disorder, with a smaller reduction in lifetime prevalence compared to DSM-IV.
DOI